This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Discover the key moments for choosing short term investments. Timing your investments can significantly impact your returns.
26,180 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
A new wave of small modular reactors could reshape the US power mix. This article explains why NuScale Power is catch...
A deep dive into AVX Q1 2026 results, revenue streams, and the implications for avax (avx) 2026 earnings. Learn what ...
An activist investor’s purchase often signals interest in a company’s next chapter. Read how Edward Garden’s stake co...
Bernstein analysts say Bitcoin’s ‘boring’ cycle persists and the store-of-value thesis remains intact despite $2.6 bi...
When a foreign gift becomes a temporary presidential plane, it illuminates how public spending, asset management, and...
July could bring a fresh wave of stock gains. This article highlights three stocks likely to lead a rally, with clear...
AI megatrends are reshaping portfolios, and Robinhood users are flocking to chipmakers. This guide highlights the thr...
Oklo stock surged as investors weighed its plans for advanced reactors against the fast-moving AI data-center boom. T...
Axon Enterprise stock soared higher after a solid earnings beat and a ambitious revenue goal. This article breaks dow...
Glamour and money collide at fashion week, but the real story lies in how high-profile families manage their finances...
Gemini Space Station stock dropped sharply after a downgrade spurred by profitability concerns and cautious guidance....